Todd Shegog - 23 Feb 2022 Form 4 Insider Report for Forma Therapeutics Holdings, Inc.

Reporting relationship: SVP, Chief Financial Officer
Issuer ticker: N/A
Reported as of: 23 Feb 2022
Net transaction value: -$55,605
SEC form: 4
Accepted by SEC: 25 Feb 2022, 16:04:13 UTC
Next SEC filing: 02 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Jeannette Potts, as Attorney-in-Fact

Key filing fact

Todd Shegog filed Form 4 for Forma Therapeutics Holdings, Inc. on 25 Feb 2022.

Key facts

This page summarizes Todd Shegog's Form 4 filing for Forma Therapeutics Holdings, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Feb 2022, 16:04.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$55,605.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FMTX transaction

Common Stock

Sale

Transaction value: $55,605
Shares: -5,687
Change %: -20%
Price: $9.78
Shares after: 22,813
Date: 23 Feb 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.61 to $10.005. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC remarks

In a Form 4 filed by the reporting person on March 2, 2021, the box indicating "no longer subject to Section 16" was inadvertently checked. The reporting person has remained subject to Section 16, and all changes in beneficial ownership subsequent to such Form 4 have been properly reported on a timely basis.